Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 1;40(12):e511-e514.
doi: 10.1097/INF.0000000000003270.

Delayed Bronchiolitis Epidemic in French Primary Care Setting Driven by Respiratory Syncytial Virus: Preliminary Data from the Oursyn Study, March 2021

Alexis Rybak  1   2   3   4 , Corinne Levy  1   2   5   6 , Camille Jung  4 , Stéphane Béchet  4 , Christophe Batard  1   2 , Frédéric Hassid  2 , Morched Zouari  2 , Fabienne Cahn-Sellem  2 , Mathieu Bangert  7 , Robert Cohen  1   2   5   6
Affiliations

Delayed Bronchiolitis Epidemic in French Primary Care Setting Driven by Respiratory Syncytial Virus: Preliminary Data from the Oursyn Study, March 2021

Alexis Rybak et al. Pediatr Infect Dis J. .

Abstract

We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.

Trial registration: ClinicalTrials.gov NCT04743609.

PubMed Disclaimer

Conflict of interest statement

C.L. received personal fees and nonfinancial support from Pfizer and Merck outside the submitted work. F.C.-S. reported personal fee and nonfinancial support from MSD Vaccines and Sanofi outside the submitted work. M.B. is employed by Sanofi Pasteur France. R.C. received personal fees and nonfinancial support from Pfizer; reported personal fees from Merck, GSK, Sanofi and AstraZeneca outside the submitted work. The other authors have no conflicts of interest to disclose.

References

    1. European Centre for Disease Prevention and Control. Data on country response measures to COVID-19. Available at: https://www.ecdc.europa.eu/en/publications-data/download-data-response-m.... Accessed 12 May, 2021.
    1. Adlhoch C, Mook P, Lamb F, et al. Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021. Euro Surveill. 2021;26:2100221.
    1. Cohen R, Béchet S, Gelbert N, et al. New approach to the surveillance of pediatric infectious diseases from ambulatory pediatricians in the digital era. Pediatr Infect Dis J. 2021;40:674–680.
    1. Santé Publique France. Bulletin épidémiologique bronchiolite. Available at: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-.... Accessed 12 May, 2021.
    1. Public Health England. National flu and COVID-19 surveillance reports. Available at: https://www.gov.uk/government/statistics/national-flu-and-covid-19-surve.... Accessed May 13, 2021.

Publication types

MeSH terms

Associated data